<VariationArchive RecordType="classified" VariationID="981982" VariationName="NC_000023.10:g.(?_153287263)_(153363189_?)dup" VariationType="Duplication" Accession="VCV000981982" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-10-25" MostRecentSubmission="2020-10-25">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="970102" VariationID="981982">
      <GeneList>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_153287263)_(153363189_?)dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="153287263" innerStop="153363189" display_start="153287263" display_stop="153363189" variantLength="75927" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_153287263)_(153363189_?)dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_153287263)_(153363189_?)dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_153287263)_(153363189_?)dup AND Non-syndromic X-linked intellectual disability" Accession="RCV001261472" Version="1">
        <ClassifiedConditionList TraitSetID="7662">
          <ClassifiedCondition DB="MedGen" ID="C3501611">Non-syndromic X-linked intellectual disability</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-07-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-07-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-10-25" MostRecentSubmission="2020-10-25">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15351775</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26605526</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27247049</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29618507</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32043567</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7662" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16731" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Non-syndromic X-linked intellectual disability</ElementValue>
                <XRef ID="MONDO:0019181" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, nonsyndromic, X-linked</ElementValue>
                <XRef Type="Phenotypic series" ID="PS309530" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XLID</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3542" />
                <XRef ID="3542" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review">
                <ID Source="PubMed">22482801</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAN/CNS, 2011">
                <ID Source="PubMed">21956720</ID>
              </Citation>
              <XRef ID="777" DB="Orphanet" />
              <XRef ID="C3501611" DB="MedGen" />
              <XRef ID="MONDO:0019181" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS309530" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2841298" SubmissionDate="2020-10-22" DateLastUpdated="2020-10-25" DateCreated="2020-10-25">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_153287263)_(153363189_?)dup|MedGen:C3501611" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001438769" DateUpdated="2020-10-25" DateCreated="2020-10-25" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15351775</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27247049</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26605526</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29618507</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32043567</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the duplication of the entire MECP2 gene. A presumed nomenclature of c.(?_-227)_(*8555_?)dup has been designated for the purposes of this classification. It has been assumed that this is a tandem duplication in direct orientation (Richardson_GIM_2018, Neuman_AJHG_2015). The variant was absent in 16120 control chromosomes (gnomAD, Structural Variants dataset). Duplications involving the MECP2 gene have been reported in the literature in multiple individuals affected with MECP2 Duplication syndrome (e.g. Lim_2017, Miguet_2018, Pascual-Alonso_2020). While the size of the duplication varies (the smallest reported duplication involves only MECP2 and IRAK1), MECP2 is always included in the duplication. Indeed, a mouse model in which MECP2 was overexpressed showed impaired coordination, seizures, hypoactivity and spasticity after 12 weeks of age (Collins_2004). Interestingly, antisense oligonucleotides which targeted MECP2 specifically and reduced expression were shown to rescue adult symptomatic MECP2 duplication mice (Sztainberg_2015), demonstrating that increased dosage of MECP2 is sufficient to explain the core phenotype of MECP2 duplication syndrome. Therefore, despite the unknown nature of the breakpoints of this variant, there is strong clinical and functional evidence to suggest duplications involving MECP2 are pathogenic for MECP2 duplication syndrome, which features include low muscle tone (hypotonia), potentially severe intellectual disability, developmental delays, recurrent respiratory infections, speech abnormalities, seizures, and progressive spasticity. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_153287263)_(153363189_?)dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Non-syndromic X-linked intellectual disability</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C3501611" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8365395</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2841298" TraitType="Disease" MappingType="Name" MappingValue="Non-syndromic X-linked intellectual disability" MappingRef="Preferred">
        <MedGen CUI="C3501611" Name="Non-syndromic X-linked intellectual disability" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

